Key result
Schizophrenia is linked to a ~22% decrease in prefrontal cortex KCC2 expression, suggesting disrupted chloride homeostasis.
Why the study?
Alterations in GABAergic neurotransmission and chloride cotransporter expression may contribute to schizophrenia pathophysiology, but protein expression abnormalities in specific brain regions were unclear.
Case-Control (n=63)
Open-label
No
Effect estimate: 22% decrease
p-value: p=<0.05
Schizophrenia is associated with decreased K-Cl cotransporter protein expression in the dorsolateral prefrontal cortex, which may be reversed by antipsychotic medications.
Should not alter schizophrenia management; hypothesis-generating for KCC2-targeted therapies in future studies.
Alterations in GABAergic neurotransmission are implicated in several psychiatric illnesses, including schizophrenia. The Na-K-Cl and K-Cl cotransporters regulate intracellular chloride levels. Abnormalities in cotransporter expression levels could shift the chloride electrochemical gradient and impair GABAergic transmission. In this study, we performed Western blot analysis to investigate whether the Na-K-Cl and K-Cl cotransporter protein is abnormally expressed in the dorsal lateral prefrontal cortex and the anterior cingulate cortex in patients with schizophrenia versus a control group. We found decreased K-Cl cotransporter protein expression in the dorsal lateral prefrontal cortex, but not the anterior cingulate cortex, in subjects with schizophrenia, supporting the hypothesis of region level abnormal GABAergic function in the pathophysiology of schizophrenia. Subjects with schizophrenia off antipsychotic medication at the time of death had decreased K-Cl cotransporter protein expression compared to both normal controls and subjects with schizophrenia on antipsychotics. Our results provide evidence for KCC2 protein abnormalities in schizophrenia and suggest that antipsychotic medications might reverse deficits of this protein in the illness.
No takes yet. Share an insight, caveat, or question.
Sullivan et al. (2015) conducted a case-control in Schizophrenia (n=63). Schizophrenia vs. Nonpsychiatrically ill comparison subjects was evaluated on KCC2 protein expression in the dorsolateral prefrontal cortex (DLPFC) (22% decrease, p=<0.05). Subjects with schizophrenia exhibited a 22% decrease in KCC2 protein expression in the dorsolateral prefrontal cortex compared to controls, suggesting disrupted intraneuronal chloride homeostasis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: